Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
Clinical trial NCT02565732 · COMPLETED
Trial details
- NCT number
- NCT02565732
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-12-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.